Back to results
US 8,268,602 B2Granted
Cellular and viral inactivation
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsYossef Raviv, Mathias Viard, Robert Blumenthal
Life of this patent
Estimating the term…
Abstract
The invention provides compositions of inactivated viruses, bacteria, fungi, parasites and tumor cells that can be used as vaccines. Methods for making such inactivated viruses, bacteria, fungi, parasites and tumor cells are also provided.
Claims10
A method of inactivating a human immunodeficiency virus, comprising the steps
- (a) contacting a human immunodeficiency virus with an effective amount of 1,5-iodonaphthyl azide
- to form a mixture of the human immunodeficiency virus and the 1,5-iodonaphthyl azide, and
- (b) exposing the mixture to ultraviolet light for a time sufficient to inactivate the human immunodeficiency virus.
A method of inactivating an Ebola virus, comprising the steps
- (a) contacting an Ebola virus with an effective amount of 1,5-iodonaphthyl azide;
- to form a mixture of the Ebola virus and the 1,5-iodonaphthyl azide, and
- (b) exposing the mixture to ultraviolet light for a time sufficient to inactivate the Ebola virus.
Dependencies are inferred from the claim text.